Bluesky Facebook Reddit Email

Enzyme may represent new target for treating asthma

05.20.19 | American Thoracic Society

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.


ATS 2019, Dallas, TX -- An enzyme called diacylglycerol kinase zeta (DGKζ) appears to play an important role in suppressing runaway inflammation in asthma and may represent a novel therapeutic target, according to research presented at ATS 2019. The researchers deleted the enzyme in mouse T cells, which drive the immune system, and found that both inflammation and airway hyper-responsiveness, two hallmarks of asthma, were reduced through independent biomolecular mechanisms.

###

VIEW ABSTRACT

Session: B29 Mechanisms for Airway Hyperresponsiveness: From Cell to Organism
Abstract Presentation Time: Monday, May 20, 9:15 a.m. CT
Location: Ballroom D Four (Level 3), Kay Bailey Hutchison Convention Center Dallas

Keywords

Contact Information

How to Cite This Article

APA:
American Thoracic Society. (2019, May 20). Enzyme may represent new target for treating asthma. Brightsurf News. https://www.brightsurf.com/news/8OJ5K3E1/enzyme-may-represent-new-target-for-treating-asthma.html
MLA:
"Enzyme may represent new target for treating asthma." Brightsurf News, May. 20 2019, https://www.brightsurf.com/news/8OJ5K3E1/enzyme-may-represent-new-target-for-treating-asthma.html.